NEUROPACE, INC. Selling, General and Administrative Expense
NEUROPACE, INC. (NPCE) reported Selling, General and Administrative Expense of $15.05 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-05-13
- NEUROPACE, INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $15.05M, a 0.36% decline year-over-year.
- NEUROPACE, INC. selling, general and administrative expense for the quarter ending 2024-12-31 was $13.79M, a 4.33% increase year-over-year.
- NEUROPACE, INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $13.91M, a 3.89% increase year-over-year.
- NEUROPACE, INC. selling, general and administrative expense for the quarter ending 2024-06-30 was $14.30M, a 1.27% decline year-over-year.
- NEUROPACE, INC. selling, general and administrative expense for fiscal 2024 was $57.10M, a 4.74% increase from fiscal 2023.
- NEUROPACE, INC. selling, general and administrative expense for fiscal 2023 was $54.52M, a 6.19% increase from fiscal 2022.
- NEUROPACE, INC. selling, general and administrative expense for fiscal 2022 was $51.34M, a 31.78% increase from fiscal 2021.
- NEUROPACE, INC. selling, general and administrative expense for fiscal 2021 was $38.96M, a 41.02% increase from fiscal 2020.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $15.05M 10-Q · filed 2025-05-13 | $28.84M derived: sum of 2 quarters · filed 2025-05-13 | $42.75M derived: sum of 3 quarters · filed 2025-05-13 | $57.05M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | $13.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $27.70M derived: sum of 2 quarters · filed 2025-03-04 | $42.00M derived: sum of 3 quarters · filed 2025-03-04 | $57.10M 10-K · filed 2025-03-04 |
| 2024-09-30 | $13.91M 10-Q · filed 2024-11-12 | $28.21M derived: sum of 2 quarters · filed 2024-11-12 | $43.31M 10-Q · filed 2024-11-12 | $56.53M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | $14.30M 10-Q · filed 2024-08-13 | $29.40M 10-Q · filed 2024-08-13 | $42.62M derived: sum of 3 quarters · filed 2025-05-13 | $56.01M derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | $15.10M 10-Q · filed 2025-05-13 | $28.32M derived: sum of 2 quarters · filed 2025-05-13 | $41.71M derived: sum of 3 quarters · filed 2025-05-13 | $56.19M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $13.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $26.61M derived: sum of 2 quarters · filed 2025-03-04 | $41.09M derived: sum of 3 quarters · filed 2025-03-04 | $54.52M 10-K · filed 2025-03-04 |
| 2023-09-30 | $13.39M 10-Q · filed 2024-11-12 | $27.87M derived: sum of 2 quarters · filed 2024-11-12 | $41.30M 10-Q · filed 2024-11-12 | $54.87M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $14.48M 10-Q · filed 2024-08-13 | $27.91M 10-Q · filed 2024-08-13 | $41.48M derived: sum of 3 quarters · filed 2024-08-13 | $54.04M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $13.43M 10-Q · filed 2024-05-08 | $27.00M derived: sum of 2 quarters · filed 2024-05-08 | $39.55M derived: sum of 3 quarters · filed 2024-05-08 | $52.33M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $13.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $26.13M derived: sum of 2 quarters · filed 2024-03-05 | $38.90M derived: sum of 3 quarters · filed 2024-03-05 | $51.34M 10-K · filed 2024-03-05 |
| 2022-09-30 | $12.55M 10-Q · filed 2023-11-06 | $25.32M derived: sum of 2 quarters · filed 2023-11-06 | $37.77M 10-Q · filed 2023-11-06 | $49.51M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $12.77M 10-Q · filed 2023-08-08 | $25.21M 10-Q · filed 2023-08-08 | $36.96M derived: sum of 3 quarters · filed 2023-08-08 | $46.38M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $12.44M 10-Q · filed 2023-05-04 | $24.19M derived: sum of 2 quarters · filed 2023-05-04 | $33.61M derived: sum of 3 quarters · filed 2023-05-04 | $43.14M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $11.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $21.17M derived: sum of 2 quarters · filed 2023-03-02 | $30.69M derived: sum of 3 quarters · filed 2023-03-02 | $38.96M 10-K · filed 2023-03-02 |
| 2021-09-30 | $9.42M 10-Q · filed 2022-11-08 | $18.95M derived: sum of 2 quarters · filed 2022-11-08 | $27.21M 10-Q · filed 2022-11-08 | $34.50M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $9.53M 10-Q · filed 2022-08-11 | $17.79M 10-Q · filed 2022-08-11 | $25.07M derived: sum of 3 quarters · filed 2022-08-11 | $32.13M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $8.27M 10-Q · filed 2022-05-12 | $15.55M derived: sum of 2 quarters · filed 2022-05-12 | $22.60M derived: sum of 3 quarters · filed 2022-05-12 | $28.21M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $14.33M derived: sum of 2 quarters · filed 2022-03-10 | $19.95M derived: sum of 3 quarters · filed 2022-03-10 | $27.63M 10-K · filed 2022-03-10 |
| 2020-09-30 | $7.05M 10-Q · filed 2021-11-10 | $12.66M derived: sum of 2 quarters · filed 2021-11-10 | $20.35M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $5.62M 10-Q · filed 2021-08-12 | $13.30M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $7.68M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |